Figure 3.
Post-immunotherapy follow-up axial T2 FLAIR MRI images of the brain. (A) 3-month, (B) 6-month, (C) 12-month, (D) 15-month contrast-enhanced MRI images with evidence of no tumor recurrence, demonstrating durable CR.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.